Home › Attention Deficit Hyperactivity Disorder › Alabama
Pag-aaral pangklinika para sa Attention Deficit Hyperactivity Disorder sa Alabama
4 pag-aaral para sa Attention Deficit Hyperactivity Disorder ang naghahanap ng mga kalahok sa mga site sa Alabama.
Opisyal na teksto ng pag-aaral (English)
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- The Center for Clinical Trials, Inc., Saraland
Nagre-recruitPhase 4
48 Months – 69 Months · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Dothan
Nagre-recruitPhase 3
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07717892Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Dothan
Nagre-recruitPhase 3
Edad 6 hanggang 11 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07717879Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
- Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05776056Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.